Skip to main content
. 2010 Aug 3;10(4):320–325. doi: 10.4161/cbt.10.4.12208

Figure 2.

Figure 2

VMY-1-13 regulation of cell cycle progression and apoptosis in the human prostate cancer cell line LNCaP. Effect of LY294002 (LY), purvalanol B (PVB) or VMY-1-103 (VMY) on HRG-induced cell cycle progression and subG1-phase associated apoptosis at (A) low and (B) high concentrations (5–10 µM). Values are percent change (average ± SD, N = 3) versus cells treated with the vehicle, DMSO. Asterisk, p ≤ 0.05.